-
Blockchain – Not Just For Bitcoin
Apr 12, 2019, 11:30 AM by Michael CroftFull storyBio-IT World | Like any new technology, blockchain must find its place. Richard Shute believes that one of those places is in the life sciences, where it can benefit researchers and drug companies while protecting patients.
-
WCG Expands its Research Site Executive Team, Global Research Network
Apr 12, 2019, 08:18 AM by Michael CroftPRINCETON, NJ - Apr 12, 2019 - The WIRB-Copernicus Group® (WCG) is pleased to announce the addition of several prominent executives to its Site Division and the expansion of its Global Research Network (GRN) of investigative sitesFull story -
OZ Makes Augmented Reality (AR) Detailing a Reality for Biopharma
Apr 11, 2019, 14:20 PM by Michael CroftFORT LAUDERDALE, FL - Apr 10, 2019 - OZ, a global consulting company enhancing customer experiences through digital innovation, recently launched a first-of-its-kind application that brings an augmented reality (AR) environment to physician DetailingFull story -
FAIR Data, A Fair Desiderata
Apr 11, 2019, 08:50 AM by Michael CroftFull storyBio-IT World | The principles of FAIR data—Findability, Accessibility, Interoperability, and Reusability—seek to improve the way data are collected and stored with the goal of preserving datasets from original research while allowing them to be reused or combined in novel ways.
-
Bio-IT World Announces 2019 Best Of Show People's Choice Award Contenders
Apr 10, 2019, 10:05 AM by Michael CroftFull storyBio-IT World | Bio-IT World is pleased to announce the 2019 Best of Show competition with the Bio-IT World People’s Choice award.
-
CluePoints Experiences Continued Rapid Growth as Demand for RBx Rises
Apr 9, 2019, 10:37 AM by Michael CroftWAYNE, PA - Apr 9, 2019 - CluePoints, a leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight solutions for clinical trials, has announced a progressive outlook of continued and significant global growth and continued investment in people and technology throughout North America, Europe and Asia PacificFull story -
Resolution Liquid Biopsy Assay Demonstrates Fewer False Positives and Higher Positive Predictive Value Than Three Known Commercial ctDNA NGS Tests
Apr 9, 2019, 10:03 AM by Michael CroftKIRKLAND, WA, UNITED STATES - Apr 9, 2019 - Resolution Bioscience, Inc., today announced that a team of AstraZeneca scientists recently published results of a study looking at assay discordance and technical variations between four leading commercial next-generation sequencing (NGS) gene panelsFull story -
Avellino Labs Welcomes James (Jim) V. Mazzo to Its Board of Directors
Apr 9, 2019, 07:09 AM by Michael CroftMENLO PARK, CA, UNITED STATES - Apr 9, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced the strategic addition of James (Jim) VFull story -
MDI Biological Laboratory to Hold Panel Discussion on the Opioid Crisis in Maine
Apr 8, 2019, 13:50 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Apr 8, 2019 - BAR HARBOR, MAINE -- The MDI Biological Laboratory and the University of New England (UNE) are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in MaineFull story -
Life Science Integrates launches new Bio Integrates to address the biggest challenges impacting the pharma and biotech sector
Apr 8, 2019, 11:20 AM by Michael CroftLONDON, UK - Apr 1, 2019 - Inspired by the success of Pharma Integrates, Life Science Integrates has introduced the new Bio Integrates conference, to be held at the Grange Tower Bridge Hotel, London, on the 22ndMay 2019Full story -
How Artificial Intelligence Will Impact Drug Development
Apr 8, 2019, 10:10 AM by Michael CroftFull storyBio-IT World | Artificial intelligence has the potential to stimulate and streamline drug discovery and development by increasing our understanding of complex biology, guiding drug design, and by assisting other more mundane elements of pharmaceutical R&D and regulatory affairs.
-
Quantabio Launches Single-Tube Lyophilized Reagent to Simplify Shipping, Storage and Setup of RT-qPCR RNA Applications
Apr 8, 2019, 09:55 AM by Michael CroftBEVERLY, MA, UNITED STATES - Apr 8, 2019 - Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today launched the Qscript lyo 1-step, a lyophilized single-reaction reagent optimized for highly sensitive and reproducible RT-qPCR RNA applicationsFull story -
HLA Typing With PacBio Shown To Improve Transplant Outcomes
Apr 5, 2019, 08:05 AM by Michael CroftFull storyBio-IT World News Brief | Scientists at the Anthony Nolan Research Institute in the UK have demonstrated that ultra-high-resolution HLA typing performed with PacBio sequencing identified stronger matches associated with improved survival rates among patients who received hematopoietic stem cell transplants. The retrospective study was published this week in the Journal of Biology of Blood and Marrow Transplantation.
-
Greenphire Launches New Tax Capability to Ease Administrative Burden and Improve Compliance for Clinical Trial Industry
Apr 4, 2019, 15:55 PM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Apr 4, 2019 - Greenphire, the global leader in financial software for clinical trials, announced today that it has released a new tax capability for its customers, easing the administrative burden of reporting, tracking, and managing tax associated with participant paymentsFull story -
Data Visualization's Use In A Data-Driven World
Apr 4, 2019, 09:25 AM by Michael CroftFull storyBio-IT World | As medicine becomes frequently data-driven, data visualization will be key to the progress of its various fields.
-
WCG Announces the Acquisition of Analgesic Solutions, LLC
Apr 4, 2019, 08:48 AM by Michael CroftPRINCETON, NJ - Apr 4, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in which pain is an indicator of an underlying conditionFull story -
Medacta Opens IPO-Season 2019 at SIX
Apr 4, 2019, 04:42 AM by Michael CroftZURICH, SWITZERLAND - Apr 4, 2019 - Today, the shares of Medacta Group SA (ticker "MOVE") were traded for the first time at SIX, opening at CHF 104xFull story -
Discovery Life Sciences Acquires HudsonAlpha Genomic Services Lab
Apr 3, 2019, 07:35 AM by Michael CroftFull storyBio-IT World News Brief | Discovery Life Science has acquired the assets, technology and staff of the HudsonAlpha Genomic Services Laboratory (GSL). Financial terms were not disclosed, but the HudsonAlpha Institute is now a shareholder of Discovery Life Sciences.
-
Strata Oncology Launches Expanded StrataNGS for Patients with Advanced Cancer
Apr 2, 2019, 13:32 PM by Michael CroftBELFORD, NJ, US - Apr 1, 2019 - Strata Oncology Launches Expanded StrataNGS for Patients with Advanced CancerUpdated StrataNGS test analyzes 500 cancer genes and reports status for three key immunotherapy biomarkers to inform the use of precision therapiesANN ARBOR, MichFull story -
Australia: Moratorium On Genetic Test Results To Be Binding Life Industry Standard
Apr 2, 2019, 12:25 PM by Michael CroftFull storyAsia Insurance Review | From 1 July 2019, the Financial Services Council (FSC) will enact the moratorium on life insurance genetic test results as a binding standard, following stakeholder feedback on the FSC Life Insurance Code of Practice consultation.